window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 5, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotech & Pharma Business

  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Norstella launches agentic AI platform for biopharma decision-making

    Norstella has launched an agentic AI platform designed to combine [...]

    August 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development

    QuantHealth raises $45M Series B to expand AI clinical trial simulation

    QuantHealth has raised $45 million in a Series B funding [...]

    August 4, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    Circio advances circular RNA gene therapy platform towards clinical development

    Circio is preparing to advance its circular RNA gene therapy [...]

    August 4, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Enzene launches local biomanufacturing model to cut biologics manufacturing costs

    Enzene has launched a biomanufacturing model designed to help governments [...]

    August 3, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy

    Aravax’s PVX108 has received FDA Fast Track designation as the [...]

    August 3, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics

    FDA approves Meitheal’s rapid-acting insulin biosimilar Garzulys

    The US Food and Drug Administration (FDA) has approved Meitheal [...]

    July 31, 2026
  • Biotech & Pharma Business,Manufacturing & Supply Chain,Research & Development

    Clean Cells acquires Anaquant to expand mass spectrometry capabilities in biopharma quality control

    Clean Cells has acquired French bioanalysis specialist Anaquant in a [...]

    July 30, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    AB2 Bio receives $30 million as Nippon Shinyaku exercises US option for rare disease drug

    AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

    July 30, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Qureight raises $20 million to expand AI imaging platform into new lung and heart diseases

    Qureight has raised $20 million in a Series B financing [...]

    July 30, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Delivery & Formulation,Pharmaceuticals and therapeutics

    PolyPid’s D-PLEX100 receives FDA Priority Review for surgical site infection prevention

    PolyPid’s D-PLEX100 has been granted FDA Priority Review following acceptance [...]

    July 29, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Vaximm reports encouraging VXM01 data in recurrent glioblastoma studies
    Categories: Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Medicus Pharma gets UAE approval to start genomics-guided endometriosis study
    Categories: Clinical & Regulatory, Drug Discovery & Development, Genomics and sequencing, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top